Madrigal Pharmaceuticals Files 8-K for Security Holder Vote
Ticker: MDGL · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1157601
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: MDGL
TL;DR
MDGL filed an 8-K for a shareholder vote - details TBD.
AI Summary
Madrigal Pharmaceuticals, Inc. filed an 8-K on June 20, 2025, to report the submission of matters to a vote of its security holders. The filing does not disclose specific details about the matters to be voted on, but it indicates that a vote will be held.
Why It Matters
This filing signals that Madrigal Pharmaceuticals is preparing for a shareholder vote, which could involve significant corporate decisions or changes that may impact investors.
Risk Assessment
Risk Level: medium — The filing itself is procedural, but the underlying matters to be voted on could carry significant risk or opportunity for the company and its shareholders.
Key Players & Entities
- MADRIGAL PHARMACEUTICALS, INC. (company) — Registrant
- June 20, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 001-33277 (company_id) — Commission File Number
- Four Tower Bridge 200 Barr Harbor Drive, Suite 200 West Conshohocken, Pennsylvania 19428 (address) — Principal executive offices
FAQ
What specific matters will be submitted for a vote by Madrigal Pharmaceuticals' security holders?
The 8-K filing states that matters are being submitted to a vote of security holders, but it does not specify what those matters are. Further information would likely be found in a proxy statement or subsequent filings.
When is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 20, 2025.
What is the Commission File Number for Madrigal Pharmaceuticals?
The Commission File Number for Madrigal Pharmaceuticals is 001-33277.
In which state is Madrigal Pharmaceuticals incorporated?
Madrigal Pharmaceuticals is incorporated in Delaware.
What is the principal executive office address for Madrigal Pharmaceuticals?
The principal executive office address is Four Tower Bridge 200 Barr Harbor Drive, Suite 200 West Conshohocken, Pennsylvania 19428.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding MADRIGAL PHARMACEUTICALS, INC. (MDGL).